{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-304736","form_type":"8-K","ticker":"ALMR","cik":"0002104204","company_name":"Alamar Biosciences, Inc.","filed_at":"2026-07-15T20:04:22+00:00","discovered_at":"2026-07-15T20:05:00.686310+00:00","generated_at":"2026-07-15T20:05:04.572948+00:00","sec_items":["8.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Alamar Biosciences announces death of board member Ian Ratcliffe; board size reduced to five","bullets":["Independent director Ian Ratcliffe, who served since February 2024, passed away on July 5, 2026.","Board decreased authorized directors from six to five following Mr. Ratcliffe's passing.","Nicholas Naclerio, Ph.D., appointed to the Audit Committee of the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-304736","json":"https://secwatch.observer/filing/0001193125-26-304736.json","markdown":"https://secwatch.observer/filing/0001193125-26-304736.md","text":"https://secwatch.observer/filing/0001193125-26-304736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2104204/000119312526304736/0001193125-26-304736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2104204/000119312526304736/d112405d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T20:05:04.572948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}